Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Treatment in Type 1 Diabetes in a Tertiary Care Center in Saudi Arabia.

Avicenna J Med · 2022 · PMC9110106 · PMID 35586391

Europe PMC DOI

hedged sentence

0.0970

closest p · 1.9× alpha

0.0970

boldest claim

The sentences

did not reach statistical significancep = 0.097so close (0.05 < p ≤ 0.1)

Additionally, the mean weight reduction was 1.7 kg from baseline to the last clinical visit; however, this did not reach statistical significance ( p = 0.097).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.